Mpox

The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox. The vaccines will be distributed across the country, with the National Health Service (NHS) prioritizing individuals...

Moderna Inc. (NASDAQ:MRNA) is developing mRNA-1769 as a mpox vaccine for use in adults. Currently, a Phase 1/2 trial evaluating the safety, tolerability, and immunogenicity of mRNA-1769 in Healthy Participants is underway. The 351-subject trial was started in 2023, and data is anticipated in 2025....

On Thursday, the European Commission said around 100,000 mpox vaccine doses arrived in the Democratic Republic of Congo (DRC), making these the first delivery of the vaccine to the country. A second delivery amounting to around 100,000 vaccines is expected to arrive in the coming days. These...

Thursday, the FDA approved Emergent BioSolutions Inc.’s (NYSE:EBS) supplemental Biologics License Application (sBLA) for the expansion of the indication for ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) to include prevention of mpox disease in individuals determined to be at high...

Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in some European and Gulf countries. The RT PCR Mpox virus detection kits are approved for sale in Europe and also authorized by the...

The World Health Organization announced a new strategic preparedness and response plan Monday in the fight against mpox, two weeks after declaring a public health emergency on the outbreak. What Happened: The WHO announced a new plan in its fight against the outbreak of mpox. The plan comes as...

Labcorp Holdings Inc (NYSE:LH) is reportedly collaborating with U.S. health regulators to determine whether it should scale up its mpox testing capabilities, following global concerns over a newly detected virus strain outside Africa. According to Marcia Eisenberg, the company's chief scientific...

On Monday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and Bilthoven Biologicals collaborated to advance TNX-801, Tonix’s mpox vaccine candidate. Bilthoven Biologicals is part of the world’s largest vaccine manufacturer, the Cyrus Poonawalla Group, which includes the Serum...

Applied DNA Sciences, Inc. (NASDAQ:APDN) stock traded higher on Friday on a strong session volume of 114.23 million, compared to the average volume of 6.78 million, according to data from Benzinga Pro. The PCR-based DNA technologies submitted a validation package to the New York State Department of...

Virax Biolabs Group Limited (NASDAQ:VRAX) shares are trading lower Thursday after the company announced a $5 million registered direct offering of ordinary shares.  The Details: Virax Biolabs has entered into a definitive agreement for the issuance and sale of an aggregate of 1,108,892 of its...

U.S. stocks showed signs of resilience as traders eagerly awaited Federal Reserve Chair Jerome Powell’s address at Jackson Hole on Friday. The minutes from the July FOMC meeting revealed that policymakers were considering a potential interest rate cut in September due to progress in curbing...

GeoVax Labs Inc (NASDAQ:GOVX) shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Michigan’s Wayne County confirmed its first case of mpox since 2022. What Happened: According to a Fox Detroit report, the Wayne County...

GeoVax Labs Inc (NASDAQ:GOVX) shares are trading lower Tuesday, pulling back from recent strength after the company announced an offering of 1.7 million shares at a price of $5 per share. What Happened: GeoVax entered into a definitive securities purchase agreement with a certain institutional...

Virax Biolabs Group Limited (NASDAQ:VRAX) shares are racing higher Monday as shares of mpox-related stocks climb after the World Health Organization (WHO) declared the virus a global health emergency last week. Virax Biolabs engages in distribution of diagnostics test kits of various viral threats...

So-called “bull traps” often frustrate traders, as they did on Wednesday, snaring shares of SIGA Technologies Inc (NASDAQ:SIGA) — and there may be another one today. That's why it’s our ‘Stock of the Day'. SIGA shares have been very active because of a surge in Mpox (The World...